Aruna Kamineni, PhD, MPH

Kamineni_Aruna__205x293.jpg

“I'm working on reducing cancer through better screening. I collaborate with researchers nationwide on studies that will make screening more effective, patient-friendly, and personalized.”

Aruna Kamineni, PhD, MPH

Assistant Investigator, Kaiser Permanente Washington Health Research Institute

Biography

Aruna Kamineni, PhD, MPH, came to Kaiser Permanente Washington Health Research Institute in 2009 with a wealth of experience in chronic disease epidemiology. Dr. Kamineni has expertise in using case-control methods to evaluate screening efficacy, and her research focuses on addressing evidence gaps for clinical guidelines, particularly for cervical and colorectal cancer prevention. A substantial portion of her work has focused on developing infrastructure and methods for research using electronic clinical and administrative health care data.

Since 2011, Dr. Kamineni has participated in the National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium to evaluate and improve cancer screening in U.S. community settings. As a principal investigator for multisite cervical and colorectal cancer PROSPR Research Centers, Dr. Kamineni is leading and collaborating on work to determine how to optimally use screening tests and consider how to tailor screening for population subgroups.

Dr. Kamineni’s research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and screening programs. Multidisciplinary collaboration is a valued and important driver of Dr. Kamineni’s research and she embraces a team science approach to optimizing cancer prevention.

Research interests and experience

  • Cancer

    Cervical cancer; colorectal cancer; screening; disparities

  • Methods

    Electronic clinical and administrative data infrastructure development for research; case-control studies; team science

Recent publications

Puricelli Perin DM, Elfström KM, Bulliard JL, Burón A, Campbell C, Flugelman AA, Giordano L, Kamineni A, Ponti A, Rabeneck L, Saraiya M, Smith RA, Broeders MJM; International Cancer Screening Network. Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: the International Cancer Screening Network COVID-19 survey. Prev Med. 2021 Oct;151:106642. doi: 10.1016/j.ypmed.2021.106642. Epub 2021 Jun 30. PubMed

Croswell JM, Corley DA, Lafata JE, Haas JS, Inadomi JM, Kamineni A, Ritzwoller DP, Vachani A, Zheng Y. Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.  Prev Med. 2021 Oct;151:106595. doi: 10.1016/j.ypmed.2021.106595. Epub 2021 Jun 30. PubMed

Puricelli Perin DM, Christensen T, Burón A, Haas JS, Kamineni A, Pashayan N, Rabeneck L, Smith R, Elfström M, Broeders MJM; International Cancer Screening Network ICSN. Interruption of cancer screening services due to the COVID-19 pandemic: lessons from previous disasters. Prev Med Rep. 2021 May 17:101399. doi: 10.1016/j.pmedr.2021.101399. Online ahead of print. PubMed

Burger EA, Jansen EE, Killen J, Kok IM, Smith MA, Sy S, Dunnewind N, G Campos N, Haas JS, Kobrin S, Kamineni A, Canfell K, Kim JJ. Impact of COVID-19-related care disruptions on cervical cancer screening in the United States. J Med Screen. 2021 Jun;28(2):213-216. doi: 10.1177/09691413211001097. Epub 2021 Mar 17. PubMed

Kamineni A, Blasi PR, Gundersen GD, Oliver M, Dunn JB, Galloway DA, Madeleine MM. Barriers to human papillomavirus vaccine series completion among insured individuals in an integrated healthcare setting.  Infect Dis (Auckl). 2021 May 20;14:11786337211018712. doi: 10.1177/11786337211018712. eCollection 2021.  PubMed

Ghai NR, Jensen CD, Merchant SA, Schottinger JE, Lee JK, Chubak J, Kamineni A, Halm EA, Skinner CS, Haas JS, Green BB, Cannizarro NT, Schneider JL, Corley DA. Primary care provider beliefs and recommendations about colorectal cancer screening in four healthcare systems. Cancer Prev Res (Phila). 2020 Nov;13(11):947-958. doi: 10.1158/1940-6207.CAPR-20-0109. Epub 2020 Jul 15. PubMed

Kamineni A, Vupputuri S. Letter to editor: challenges in evaluating diversity and inclusion in scientific communities. Am J Epidemiol. 2020 Jun 30:kwaa115. doi: 10.1093/aje/kwaa115. [Epub ahead of print]. PubMed

Hua X, Newcomb PA, Chubak J, Malen RC, Ziebell R, Kamineni A, Zhu LC, Upton MP, Wurscher MA, Thomas SS, Newman H, Hardikar S, Burnett-Hartman AN. Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control. 2020 May 1. doi: 10.1007/s10552-020-01304-1. [Epub ahead of print]. PubMed

Chen L, Shortreed SM, Easterling T, Cheetham TC, Reynolds K, Avalos LA, Kamineni A, Holt V, Neugebauer R, Akosile M, Nance N, Bider-Canfield Z, Walker RL, Badon SE, Dublin S. Identifying hypertension in pregnancy using electronic medical records: the importance of blood pressure values.  Pregnancy Hypertens. 2020 Jan;19:112-118. doi: 10.1016/j.preghy.2020.01.001. Epub 2020 Jan 3. PubMed

Ko CW, Doria-Rose VP, Barrett MJ, Kamineni A, Enewold L, Weiss NS. Screening colonoscopy and flexible sigmoidoscopy for reduction of colorectal cancer incidence: a case-control study. PLoS One. 2019 Dec 5;14(12):e0226027. doi: 10.1371/journal.pone.0226027. eCollection 2019. PubMed

 

Research

Cancer-prevention-story_1col.jpg

Improving cancer prevention and early detection

How KPWHRI is contributing to better cancer screening and better outcomes for patients.

Healthy findings blog

QA_Cancer-Harm_illustration_1col.jpg

Improving reporting of cancer screening harms

Aruna Kamineni, PhD, MPH, discusses her recent study on how guidelines report screening risks.

innovating care

Fit-Kit-Colon-testing_1col.jpg

How to maximize screening for colon cancer

Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.

KPWHRI in the Media

Aruna Kamineni, PhD, MPH, comments on new study of cancer screening guidelines

NCI study analyzes the harms from cancer screening

Managed Healthcare Executive, Dec. 8, 2022